Results 11 to 20 of about 306,427 (234)

MYOCARDIAL REMODELLING TYPES IN HYPERTROPHIC NON-OBSTRUCTIVE CARDIOMYOPATHY [PDF]

open access: yesРоссийский кардиологический журнал, 2015
Aim. To evaluate the prevalence of the left ventricle remodeling types in hypertrophic non-obstructive cardiomyopathy, and their relation to clinical and instrumental data. Material and methods.
D. V. Bogdanov
doaj   +2 more sources

DYNAMICS OF CARDIOVASCULAR SYSTEM PARAMETERS ON A BACKGROUND OF APPLICATION OF ADRENERGIC BLOCKERS IN CHILDREN WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

open access: yesПедиатрическая фармакология, 2007
The article is dedicated to the issue of curing children with obstructive form of hypertrophic cardiomyopathy. It presents a complex evaluation of adrenergic blockers influence on the clinical finding, heart rate disorder and vegetative regulation of ...
E.A. Tikhomirova   +3 more
doaj   +3 more sources

HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
Hypertrophic cardiomyopathy (HCMP) is a relatively common disease with genetic predisposition, that is widely spread irrespective of gender, race or ethnicity. The cause of this pathology are mutations of genes encoding synthesis of contracting proteins.
A. G. Osiev   +4 more
doaj   +3 more sources

LEOPARD syndrome and hypertrophic obstructive cardiomyopathy: a case report [PDF]

open access: yesThe Turkish Journal of Pediatrics, 2004
The LEOPARD syndrome is a rare, autosomal dominant multisystemic disorder characterized by lentiginosis, ocular hypertelorism, abnormal genitalia, growth retardation, sensorineural deafness, and cardiac and electrocardiographic abnormalities ...
Ergun Cetinkaya   +6 more
doaj   +2 more sources

Hypertrophic cardiomyopathy with mid-ventricular obstruction and apical aneurysm [PDF]

open access: yesКардіохірургія та інтервенційна кардіологія, 2016
A case report of apical left ventricular aneurysm in patient with hypertrophic cardiomyopathy with mid-ventricular obstruction (diagnosis and surgical treatment) is presented.
N.D. Oryshchyn   +6 more
doaj   +1 more source

Hypertrophic obstructive cardiomyopathy [PDF]

open access: yesThe Lancet, 2017
Hypertrophic obstructive cardiomyopathy is an inherited myocardial disease defined by cardiac hypertrophy (wall thickness ≥15 mm) that is not explained by abnormal loading conditions, and left ventricular obstruction greater than or equal to 30 mm Hg. Typical symptoms include dyspnoea, chest pain, palpitations, and syncope.
Veselka, Josef   +2 more
openaire   +4 more sources

Hypertrophic Obstructive Cardiomyopathy [PDF]

open access: yesDeutsches Ärzteblatt international, 2019
Hypertrophic cardiomyopathy (HCM) is caused by mutations in a number of genes. Its prevalence is 0.2% to 0.6%.This review is based on publications retrieved by a selective literature search and on the authors' clinical experi- ence.70% of patients with HCM suffer from the obstructive type of the condition, clinically characterized by highly dynamic and
Angelika, Batzner   +3 more
openaire   +3 more sources

Symptomatic Obstructive Hypertrophic Cardiomyopathy [PDF]

open access: yesCirculation: Cardiovascular Interventions, 2013
Hypertrophic cardiomyopathy (HCM) is a common, yet challenging condition for clinical management. The majority of these patients have evidence of left ventricular outflow tract (LVOT) obstruction that may be asymptomatic or associated with debilitating symptoms of heart failure.
Paul, Sorajja   +2 more
openaire   +2 more sources

Quality first in obstructive hypertrophic cardiomyopathy

open access: yes, 2021
Increasing clinician awareness, earlier diagnosis, and implantable cardioverter-defibrillators have allowed hypertrophic cardiomyopathy to transition from being a relatively common cause of sudden death in young people to a chronic disease affecting ...
Prasad, Sandhir B   +3 more
core   +1 more source

Diagnosis and Treatment of Obstructive Hypertrophic Cardiomyopathy [PDF]

open access: yes, 2023
Left ventricular outflow obstruction (LVOTO) and diastolic dysfunction are the main pathophysiological characteristics of hypertrophic cardiomyopathy (HCM)LVOTO, may be identified in more than half of HCM patients and represents an important determinant ...
Errico Federico Perillo   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy